These are accepted for thetreatment of psoriatic arthritis, ulcerative colitis, rheumatoid arthritis, andankylosing spondylitis, golimumab is a completely humanized anti-TNF monoclonalantibody. The gene discussed is TNF; the disease is rheumatoid arthritis.